Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 6,244 | 4,780 | 3,117 | 7,127 | 6,830 |
| Gross Profit | 6,244 | 4,780 | 3,117 | 7,127 | 6,830 |
| Operating Expenses | 9,608 | 10,317 | 10,523 | 13,293 | 14,356 |
| Operating Income | -3,365 | -5,537 | -7,407 | -6,167 | -7,526 |
| Interest Expense | 946 | 922 | 948 | 888 | 749 |
| Other Income | -18 | 66 | 410 | 1,383 | -5,688 |
| Pre-tax Income | -4,328 | -6,393 | -7,944 | -5,672 | -13,963 |
| Net Income Continuous | -4,328 | -6,393 | -7,944 | -5,672 | -13,963 |
| Net Income | $-4,328 | $-6,393 | $-7,944 | $-5,672 | $-13,963 |
| EPS Basic Total Ops | -42.04 | -66.07 | -84.08 | -60.06 | -150.15 |
| EPS Basic Continuous Ops | -40.68 | -64.81 | -84.68 | -61.79 | -149.34 |
| EPS Diluted Total Ops | -42.04 | -66.07 | -84.08 | -60.06 | -150.15 |
| EPS Diluted Continuous Ops | -40.68 | -64.81 | -84.68 | -61.79 | -149.34 |
| EBITDA(a) | $-3,107 | $-5,283 | $-7,161 | $-5,934 | $-7,278 |